BARI USA

(redirected from Bypass Angioplasty Revascularization Investigation)
Also found in: Acronyms.

BARI USA

Bypass Angioplasty Revascularization Investigation USA. A trial comparing the pros and cons of percutaneous transluminal angioplasty (PTCA) to coronary artery bypass graft surgery (CABG) in managing patients with multivessel coronary artery disease.
 
Conclusion 
(1) No difference in survival;
(2) PTCA carries an increased need for late repeat revascularisation;
(3) PCTA has an increased mortality in diabetics.
References in periodicals archive ?
The analysis he presented focused on patients enrolled in the BAR12D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes), which randomized a total of 2,368 patients with diabetes and documented coronary ischemia and stenosis suitable for an elective intervention.
In the BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes) study, patients with type 2 diabetes and documented CAD have been randomized to immediate revascularization combined with aggressive medical management, or a program of aggressive medical management with delayed or no revascularization.
Bypass Angioplasty Revascularization Investigation. Native coronary disease progression exceeds failed revascularization as cause of angina after five years in the Bypass Angioplasty Revascularization Investigation (BARI).
But this represents a considerable narrowing of the historic gap between the two strategies observed in earlier classic studies such as the Bypass Angioplasty Revascularization Investigation (BARI) and the Emory Angioplasty vs.
In the 1996 Bypass Angioplasty Revascularization Investigation, diabetic patients fared better with CABG than with PTCA.